Skip to main content
All
Stories
Press Releases
Documents
Events
Updates
Other
Press shift tab to select search category
Loading...
Press Releases
Investors
Partnering
Careers
< Back
Careers
Careers
Working at Ipsen
All
Stories
Press Releases
Documents
Events
Updates
Other
Press shift tab to select search category
X
Loading...
English EN
Français FR
EN
English
EN
Français
FR
Canada
< Back
Global
EN
FR
Annual Report
EN
FR
Americas
Asia Pacific
Europe
Middle East & Africa
United States
Brazil
Canada
Mexico
Australia
China
Singapore
South Korea
Japan
Belgium
Ukraine
UK
Germany
France
Nordics
Greece
Italy
Netherlands
Spain
Poland
Russia
Czech Republic
Switzerland
Austria
UAE & Gulf
Saudi Arabia
Home
Company
< Back
Company
Who We Are
Leadership
Our History
Science
< Back
Science
Areas of Focus
Products
Clinical Trials
R&D
Grant Requests
Investigator Sponsored Studies
Sustainability
< Back
Sustainability
Sustainability
Environment
People
Governance
Charitable Contributions
Patients
Post navigation
Previous
Next
Somatuline Autogel
®
(lanreotide injection)
Somatuline Autogel
®
(lanreotide injection)
-
20 August 2024
-
0 mins read
Post navigation
Previous
Next
Related Documents
Click here to view Product Monograph
(1 MB)
X
You are now leaving the Ipsen Canada website. To continue, please click Continue.
